These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17342480)

  • 1. Pharmacokinetic study of the interaction between itraconazole and nevirapine.
    Jaruratanasirikul S; Sriwiriyajan S
    Eur J Clin Pharmacol; 2007 May; 63(5):451-6. PubMed ID: 17342480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect.
    Varis T; Kivistö KT; Backman JT; Neuvonen PJ
    Clin Pharmacol Ther; 2000 Nov; 68(5):487-94. PubMed ID: 11103751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of piperine on the pharmacokinetics of nevirapine under fasting conditions: a randomised, crossover, placebo-controlled study.
    Kasibhatta R; Naidu MU
    Drugs R D; 2007; 8(6):383-91. PubMed ID: 17963429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of clinically relevant drug interactions following simultaneous administration of didanosine-encapsulated, enteric-coated bead formulation with either itraconazole or fluconazole.
    Damle B; Hess H; Kaul S; Knupp C
    Biopharm Drug Dispos; 2002 Mar; 23(2):59-66. PubMed ID: 11932960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, pharmacokinetics, and pharmacodynamics of cyclodextrin itraconazole in pediatric patients with oropharyngeal candidiasis.
    Groll AH; Wood L; Roden M; Mickiene D; Chiou CC; Townley E; Dad L; Piscitelli SC; Walsh TJ
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2554-63. PubMed ID: 12121932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itraconazole increases plasma concentrations of quinidine.
    Kaukonen KM; Olkkola KT; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Nov; 62(5):510-7. PubMed ID: 9390107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selegiline pharmacokinetics are unaffected by the CYP3A4 inhibitor itraconazole.
    Kivistö KT; Wang JS; Backman JT; Nyman L; Taavitsainen P; Anttila M; Neuvonen PJ
    Eur J Clin Pharmacol; 2001 Apr; 57(1):37-42. PubMed ID: 11372588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the metabolism of etizolam by itraconazole in humans: evidence for the involvement of CYP3A4 in etizolam metabolism.
    Araki K; Yasui-Furukori N; Fukasawa T; Aoshima T; Suzuki A; Inoue Y; Tateishi T; Otani K
    Eur J Clin Pharmacol; 2004 Aug; 60(6):427-30. PubMed ID: 15232663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of dose-dependent effects of itraconazole on the pharmacokinetic interaction with fexofenadine.
    Uno T; Shimizu M; Sugawara K; Tateishi T
    Drug Metab Dispos; 2006 Nov; 34(11):1875-9. PubMed ID: 16928786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide.
    Niemi M; Backman JT; Neuvonen M; Neuvonen PJ
    Diabetologia; 2003 Mar; 46(3):347-51. PubMed ID: 12687332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Itraconazole greatly increases plasma concentrations and effects of felodipine.
    Jalava KM; Olkkola KT; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Apr; 61(4):410-5. PubMed ID: 9129558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone.
    Jaakkola T; Backman JT; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2005 May; 77(5):404-14. PubMed ID: 15900286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of grapefruit juice on pharmacokinetics of itraconazole in healthy subjects.
    Kawakami M; Suzuki K; Ishizuka T; Hidaka T; Matsuki Y; Nakamura H
    Int J Clin Pharmacol Ther; 1998 Jun; 36(6):306-8. PubMed ID: 9660036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients.
    Sriwiriyajan S; Mahatthanatrakul W; Ridtitid W; Jaruratanasirikul S
    Eur J Clin Pharmacol; 2007 May; 63(5):479-83. PubMed ID: 17345073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic interactions between ciprofloxacin and itraconazole in healthy male volunteers.
    Sriwiriyajan S; Samaeng M; Ridtitid W; Mahatthanatrakul W; Wongnawa M
    Biopharm Drug Dispos; 2011 Apr; 32(3):168-74. PubMed ID: 21360715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of nevirapine: once-daily versus twice-daily dosing in the 2NN study.
    Kappelhoff BS; Huitema AD; van Leth F; Robinson PA; MacGregor TR; Lange JM; Beijnen JH;
    HIV Clin Trials; 2005; 6(5):254-61. PubMed ID: 16306032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin.
    Ducharme MP; Slaughter RL; Warbasse LH; Chandrasekar PH; Van de Velde V; Mannens G; Edwards DJ
    Clin Pharmacol Ther; 1995 Dec; 58(6):617-24. PubMed ID: 8529326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of nevirapine administration on the pharmacokinetics of dolutegravir in patients infected with HIV-1.
    Dailly E; Allavena C; Grégoire M; Reliquet V; Bouquié R; Billaud E; Hernando H; Bouchez S; Deslandes G; Hall N; Jolliet P; Raffi F
    J Antimicrob Chemother; 2015 Dec; 70(12):3307-10. PubMed ID: 26271944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic interaction of nadolol with itraconazole, rifampicin and grapefruit juice in healthy volunteers.
    Misaka S; Miyazaki N; Yatabe MS; Ono T; Shikama Y; Fukushima T; Kimura J
    J Clin Pharmacol; 2013 Jul; 53(7):738-45. PubMed ID: 23677858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nevirapine on the steady-state trough concentrations of atazanavir in HIV-infected patients receiving atazanavir/ritonavir.
    Moltó J; Deig E; Valle M; Maria Llibre J; Miranda C; Cedeño S; Valero S; Negredo E; Clotet B
    Ther Drug Monit; 2010 Feb; 32(1):93-6. PubMed ID: 20040897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.